Quarterly Cash Report at 30 September 2020

Uscom Q1 FY21 4C Report

"For Uscom the story remains- rapidly growing fundamentals with blue sky ahead. These Q1record results endorse our current strategy demonstrating persistent outstanding growth and establish new trends of profit and cash flow positivity. Meanwhile the number of new Uscom products building up for imminent release continues to increase as our global distribution network expands. Q1is historically our slowest quarter, but for this quarter growth has exceeded expectations despite the COVID-19 pandemic limiting hospital operations and delaying regulatory approval processes. This success largely represents the growth in operations of Uscom China as the Chinese economy rebounds. We anticipate this rebound will spread to global markets as other countries recover and invest in expanding health care systems as protection for future seasonal infectious diseases."

Prof. Rob Phillips

Uscom has released its Appendix 4C - cash flow report for the quarter ending 30 September 2020.

  • Sales Revenue $1.26M - up 413%
  • Cash receipts $1.43M - up 75%
  • Profitable and cash flow positive
  • Cash on hand $2.01M increased from Q4
BACK TO TOP